Analyst Research
| Report Title | Price |
|---|---|
|
Trading Report for (VAR). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Market Edge
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Varian Medical Systems Inc Announces Board Changes
Varian Medical Systems Inc announced that Timothy E. Guertin has declared his intention to retire as the Company's President and CEO at the end of the Company's current fiscal year on September 28, 2012. Varian's Board of Directors has elected Dow R. Wilson, the Company's current Executive Vice President and Chief Operating Officer, to become Varian's President and CEO upon Guertin's retirement. Guertin will continue as a non-executive employee of the Company until his retirement in February 2013.
Latest Developments for Varian Medical Systems Inc
- Varian Medical Systems Inc Receives FDA 510(k) Clearance Of Its Nexus DRF Digital X-Ray Imaging System
- Varian Medical Systems Inc Issues Q3 2013 Guidance; EPS Guidance Below Analysts' Estimates; Reaffirms FY 2013 Guidance
- Varian Medical Systems Inc Receives FDA 510(k) Clearance For Edge Radiosurgery Suite For Non-Invasive Surgical Procedures
- Varian Medical Systems Inc Issues Q2 2013 Guidance; Revenue Guidance Below Analysts' Estimates; Reaffirms FY 2013 Revenue Guidance; Raises Low End Of Prior FY 2013 EPS Guidance-Conference Call
Latest Key Developments in Advanced
- Volcano Corp Announces Preliminary Results From ADVISE II Study
- Nordion Inc Enters Into Agreement To Divest Targeted Therapies Business To BTG Plc
- Raysearch Laboratories AB publ Appoints Ernst & Young as Auditors
- Varian Medical Systems Inc Receives FDA 510(k) Clearance Of Its Nexus DRF Digital X-Ray Imaging System
- Share this
- Link this
- Digg this
Follow Reuters